Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature. | Genes (Basel) | 2023 | 37895315 | Swiss-Prot, curated | PubMed |
| The PERK Branch of the Unfolded Protein Response Safeguards Protein Homeostasis and Mesendoderm Specification of Human Pluripotent Stem Cells. | Adv Sci (Weinh) | 2023 | 37890465 | PubTator, text mining | PubMed |
| The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening. | Curr Issues Mol Biol | 2023 | 37886977 | PubTator, text mining | PubMed |
| Integrative genome-scale analyses reveal post-transcriptional signatures of early human small intestinal development in a directed differentiation organoid model. | BMC Genomics | 2023 | 37884859 | PubTator, text mining | PubMed |
| Spatial Single Cell Analysis of Proteins in 2D Human Gastruloids Using Iterative Immunofluorescence. | Curr Protoc | 2023 | 37882990 | PubTator, text mining | PubMed |
| Regeneration of Pancreatic Cells Using Optimized Nanoparticles and l-Glutamic Acid-Gelatin Scaffolds with Controlled Topography and Grafted Activin A/BMP4. | ACS Biomater Sci Eng | 2023 | 37882705 | PubTator, text mining | PubMed |
| ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma. | Cell Death Discov | 2023 | 37880213 | PubTator, text mining | PubMed |
| BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells. | Nucleic Acids Res | 2023 | 37870468 | PubTator, text mining | PubMed |
| Reliability of human retina organoid generation from hiPSC-derived neuroepithelial cysts. | Front Cell Neurosci | 2023 | 37868194 | PubTator, text mining | PubMed |
| Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer. | Cancer Lett | 2023 | 37866545 | PubTator, text mining | PubMed |
| DNMT3A-mediated epigenetic silencing of SOX17 contributes to endothelial cell migration and fibroblast activation in wound healing. | PLoS One | 2023 | 37856473 | PubTator, text mining | PubMed |
| Modelling in vitro gametogenesis using induced pluripotent stem cells: a review. | Cell Regen | 2023 | 37843621 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. | Cancer Cell Int | 2023 | 37840147 | PubTator, text mining | PubMed |
| Derivation of Arbas Cashmere Goat Induced Pluripotent Stem Cells in LCDM with Trophectoderm Lineage Differentiation and Interspecies Chimeric Abilities. | Int J Mol Sci | 2023 | 37834175 | PubTator, text mining | PubMed |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Int J Mol Sci | 2023 | 37833856 | PubTator, text mining | PubMed |
| Dual mechanism of Let-7i in tumor progression. | Front Oncol | 2023 | 37829341 | PubTator, text mining | PubMed |
| Gastruloid optimization. | Emerg Top Life Sci | 2023 | 37815089 | PubTator, text mining | PubMed |
| Generation of 3D lung organoids from human induced pluripotent stem cells for modeling of lung development and viral infection. | Heliyon | 2023 | 37809493 | PubTator, text mining | PubMed |
| A mutant methionyl-tRNA synthetase-based toolkit to assess induced-mesenchymal stromal cell secretome in mixed-culture disease models. | Stem Cell Res Ther | 2023 | 37798772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=18